期刊文献+

肌钙蛋白和C-反应蛋白在缺血性心肌病与扩张型心肌病中的变化 被引量:1

Changes of serum cardiac troponin and C-reactive protein in the patients with ischemic cardiomyopathy and dilated cardiomyopathy
暂未订购
导出
摘要 目的探讨肌钙蛋白(cTn-I)和超敏C-反应蛋白(hs-CRP)在缺血性心肌病与扩张型心肌病患者中的变化。方法101例心肌病患者行冠脉造影检查,分为缺血性心肌病组(ICM组,53例)和扩张型心肌病组(DCM组,48例)。测定患者在不同NYHA分级时血清cTn-I和hs-CRP浓度。结果ICM患者平均血清hs-CRP浓度高于DCM患者,分别为(4.13±1.07)和(2.64±1.19)mg/L;在相同NYHA时,ICM患者的血清hs-CRP浓度明显高于DCM患者(P<0.01)。ICM患者血清平均cTn-I浓度与DCM患者相似,分别为(0.31±0.27)和(0.34±0.33)μg/L;ICM和DCM患者血清cTn-I浓度在相同NYHA时比较无显著性差异(P>0.05)。无论是ICM患者还是DCM患者,血清hs-CRP和cTn-I浓度均随心衰程度加重而增高,NYHAⅢ和Ⅳ级患者血清hs-CRP和cTn-I浓度明显高于NYHAⅠ和Ⅱ级患者(P<0.01)。结论ICM患者和DCM患者血清hs-CRP和cTn-I浓度随心衰程度加重而增高。ICM患者血清hs-CRP浓度明显高于DCM患者,而两组cTn-I浓度比较无显著性差异。心衰患者cTn-I升高非冠状动脉缺血所致,而与心衰本身有关。 Objective To investigate the level of serum cardiac troponin I(cTn-I) and high-sensitivity C-reactive protein(hs-CRP) in the patients with ischemic cardiomyopathy(ICM) and dilated cardiomyopathy(DCM). Methods According to the results of coronary angiography, 101 cases of cardiomyopathy patients were divided into group DCM showing normal coronary arteries and group ICM showing coronary heart disease, cTn-I and hs-CRP levels were measured at different NYHA cardiac function classes. Results Average hs-CRP level in patients with ICM was higher than that in patients with DCM [(4.13±1.07) and (2.64±1.19)mg/L]. At the same class of cardiac function,hs-CRP levels in patients with ICM were significantly higher than those in patients with DCM(P〈0.01). Average cTn-I levels in ICM group and DCM group were similar [(0.31±0.27) and (0.34±0.33) μg/L]. At the same class of cardiac function, the levels of serum cTn-I were similar between ICM group and DCM group(P〉0.05). Both in ICM group and DCM group, higher the class of cardiac function, higher the levels of serum cTn-I and hs-CRP. Patients with NYHA Ⅲ and Ⅳ had higher cTn-I and hs-CRP levels compared with patients with NYHA Ⅰand NYHA Ⅱ in both groups(P 〈0.05). Conclusion The hs-CRP levels in patients with ICM were significantly higher than those in patients with DCM, while the levels of serum cTn-I were similar between ICM group and DCM group. Permanent cTn-I release is a common finding in patients with chronic heart failure. In this setting, coronary lesion seems to play a minor role in disease progression. High levels of hs-CRP and serum cTn-I are associated with features of severe heart failure.
出处 《中华老年多器官疾病杂志》 2008年第1期23-25,共3页 Chinese Journal of Multiple Organ Diseases in the Elderly
关键词 C-反应蛋白 肌钙蛋白Ⅰ 心肌病 扩张型 心肌病 缺血性 C-reactive protein troponin Ⅰ cardiomyopathy, dilated cardiomyopathy, ischemic
  • 相关文献

参考文献11

  • 1[1]Richardson P,McKenna W,Bristow M,et al.Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies.Circulation,1996,93:841-842.
  • 2[2]Kaneko K,Kanda T,Yamauchi Y,et al.C-reactive protein in dilated cardiomyopathy.Cardiology,1999,91:215-219.
  • 3[3]Alortso-Martinez JL,Llorente-Diez B,Echegaray-Agara M,et al.C-reactive protein as a predictor of improvement and readmission in heart failure.Eur J Heart Fail,2002,4:331-336.
  • 4[4]Vasan RS,Sullivan LM,Roubenoff R,et al.Framingham Heart Study.Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction.Circulation,2003,107,1486-1491.
  • 5[5]Yin WH,Chen Jw,Jen HL,et al.Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure.Am Heart J,2004,147:931-938.
  • 6[6]Werdan K.The activated immune system in congestive heart failure-from dropsy to the cytokine paradigm.J Intern Med,1998,243:87-92.
  • 7[7]Filipovic M,Jeger R,Probst C,et al.Heart rate vafiability and cardiac troponin I are incremental and independent predictors of one year all-cause mortality after major noncardiac surgery in patients at risk of coronary artery disease.J Am Coll Cardiol,2003,42:1767-1776.
  • 8[8]Ishii J,Nomura M,Nakamura Y,et al.Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure.Am J Cardiol,2002,89:691-695.
  • 9[9]Ishii J,Cui W,Kitagawa F,et al.Prognostic value of combination of cardiac troponin T and B-type natriuretic peptide after initiation of treatment in patients with chronic heart failure.Clin Chem,2003,49:2020-2026.
  • 10[10]La Vecchia L,Mezzena G,Ometto R,et al.Detectable serum troponin I in patients with heart failure of nonmyocardial ischemic origin.Am J Cardiol,1997,80:88-90.

同被引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部